Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPIDER-PCI: Varespladib to Decrease Enzyme Release After PCI
NCT00533039Phase 2Completed
- Sponsor
- University Health Network
- Start
- Oct 2007
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of varespladib in coronary artery disease (CAD), sponsored by University Health Network. Started Oct 2007; status: completed.
02
Drugs
varespladib
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00533039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00533039.